Cancer Therapy News and Research

RSS

UCLA researchers identify new drug delivery pathway to stop tumor growth

Researchers at the UCLA Jonsson Comprehensive Cancer Center have identified a new drug delivery pathway that may help stop tumor growth and keep cancer from coming back in mice.

25 Sep 2019

Men with prostate cancer want access to female doctors

Malecare, America’s largest men’s cancer support network, this week announced the world’s first prostate cancer patient conference to feature an all-female faculty featuring twelve of the U.S.A.’s top prostate cancer clinicians

25 Sep 2019

Targeting cancer patients' mindsets could improve their health and well-being

A diagnosis of cancer can cause significant emotional burden for patients and their families. The turmoil may persist throughout treatment and even years into survivorship.

25 Sep 2019

Cryoablation procedure could be an alternative to surgery for breast cancer

When Jeanne Anderson was diagnosed with breast cancer three years ago, the Beverly Hills resident underwent a course of chemotherapy to shrink the tumors in preparation for surgery.

24 Sep 2019

Wake Forest Baptist receives multimillion-dollar grant for innovative cancer care research

For the second time in five years, Wake Forest Baptist Health has been recognized for its expertise in conducting innovative cancer care research by the National Cancer Institute's Community Oncology Research Program with a multimillion-dollar grant.

23 Sep 2019

Light-activated metal compound cuts off cancer cell's 'power source'

A space-age metal that formed part of the asteroid that destroyed the dinosaurs could provide a new method of treating cancer tumors selectively using light.

23 Sep 2019

Version of an antibiotic drug extends survival in mice with lethal pediatric brain tumors

Versions of an antibiotic drug called DON first isolated from soil bacteria more than 60 years ago have shown promising signs of extending survival in mice models of especially lethal pediatric brain tumors marked by the high expression of a cancer-causing gene known as the MYC oncogene, according to results of two studies from researchers at the Johns Hopkins Kimmel Cancer Center.

23 Sep 2019

UTHealth's innovative cancer-fighting projects receive $11 million CPRIT funding

Five innovative cancer-fighting projects at The University of Texas Health Science Center at Houston received just over $11 million during the latest round of grants awarded by the Cancer Prevention and Research Institute of Texas

21 Sep 2019

Mitochondrial fission factor could represent a promising target for cancer therapy

Researchers at The Wistar Institute have described the role of mitochondrial fission factor (MFF) in controlling survival of cancer cells, suggesting the protein could represent a promising therapeutic target. They also found that expression of MFF is regulated by Myc, a ubiquitous mediator of cell proliferation that contributes to development of many cancer types.

20 Sep 2019

Early palliative care linked to better survival in patients with advanced lung cancer

Early palliative care is associated with better survival in patients with advanced lung cancer, according to a study by VA Portland Health Care System and Oregon Health and Science University researchers.

19 Sep 2019

New protein could offer a fresh target for cancer treatment

A study has revealed a drug target called the mitoNEET cell protein, which determines how materials are transported from the mitochondria to the rest of the cell.

19 Sep 2019

Researchers discover how cancer cells can trigger chronic muscle wasting condition

A solid tumor can cause muscle cells in the body to self-destruct. Many cancer patients die from the consequences. Now researchers are discovering more about how cancer cells in a tumor can take control of muscle cell wasting and trigger a chronic, serious condition.

19 Sep 2019

Low-dose aspirin may improve survival in patients with head and neck, lung cancers

What if a drug that sits in nearly everyone's medicine cabinet could help extend the lives of some cancer patients? In companion presentations at the American Society for Therapeutic Radiation Oncology Annual Meeting in Chicago, doctors from Roswell Park Comprehensive Cancer Center report new evidence that low-dose aspirin and other anti-inflammatories may improve survival in patients undergoing treatment for some head/neck and lung cancers.

19 Sep 2019

Nearly half of NCI-sponsored trials on clinical cancer were associated with new drug approvals

A new study shows that nearly half of phase 3 cancer clinical trials carried out by the National Cancer Institute (NCI)-sponsored SWOG Cancer Research Network, one of five groups in NCI's National Clinical Trials Network (NCTN), were associated with clinical care guidelines or new drug approvals. NCI is part of the National Institutes of Health.

19 Sep 2019

NUS chemists develop new anti-cancer drug with less renal toxicity

A team of pharmacists and chemists from the National University of Singapore has developed a new anti-cancer drug that has less toxic effects to the kidneys.

18 Sep 2019

Compound could play a novel role in halting spread of pancreatic cancer

In early test tube and mouse studies, investigators at Johns Hopkins Medicine and the Johns Hopkins Kimmel Cancer Center have found that nonmuscle myosin IIC (MYH14), a protein activated in response to mechanical stress, helps promote metastatic behavior in pancreatic cancer cells, and that the compound 4-hydroxyacetophenone (4-HAP), known to stiffen myosin IIC-containing cells, can send it into overdrive, overwhelming the ability of cells to invade nearby tissue.

18 Sep 2019

Patients with non-Hodgkin's lymphoma may benefit from radiation, experience reduced side effects

Treating non-Hodgkin's lymphoma patients with radiation therapy as an additional treatment while they wait for their CAR T cells to be manufactured may reduce the risk of CAR T therapy side effects once it is administered, according to a new study from researchers in the Abramson Cancer Center at the University of Pennsylvania.

18 Sep 2019

Cancer Therapy News and Research

UCLA researchers identify new drug delivery pathway to stop tumor growth

Men with prostate cancer want access to female doctors

Targeting cancer patients' mindsets could improve their health and well-being

Cryoablation procedure could be an alternative to surgery for breast cancer

Wake Forest Baptist receives multimillion-dollar grant for innovative cancer care research

Light-activated metal compound cuts off cancer cell's 'power source'

Version of an antibiotic drug extends survival in mice with lethal pediatric brain tumors

UTHealth's innovative cancer-fighting projects receive $11 million CPRIT funding

Mitochondrial fission factor could represent a promising target for cancer therapy

Early palliative care linked to better survival in patients with advanced lung cancer

New protein could offer a fresh target for cancer treatment

Researchers discover how cancer cells can trigger chronic muscle wasting condition

Low-dose aspirin may improve survival in patients with head and neck, lung cancers

Nearly half of NCI-sponsored trials on clinical cancer were associated with new drug approvals

NUS chemists develop new anti-cancer drug with less renal toxicity

Compound could play a novel role in halting spread of pancreatic cancer

Patients with non-Hodgkin's lymphoma may benefit from radiation, experience reduced side effects

Men with prostate cancer can have healthy sex lives after surgery

New AI-guided robotic platform for automation of synthetic biological molecules

Advanced imaging technology may offer new treatment for cancer

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News